Ajani, J A <br/><br/>
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane.  [electronic resource] 

 -  Investigational new drugs  Sep 2006 
 - 441-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1007/s10637-006-7304-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Bridged-Ring Compounds--therapeutic use<br/>Disease Progression<br/>Epothilones--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Peripheral Nervous System Diseases--chemically induced<br/>Stomach Neoplasms--drug therapy<br/>Taxoids--therapeutic use